Evidence map›Paper›PMID 23221473›Full record

ReviewVirulence2012

Use and abuse of dendritic cells by Toxoplasma gondii.

Anna Sanecka, Eva-Maria Frickel

Abstract readReview
In one paragraph

Review in Virulence, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Review
  2. Vaccines · 2025
    Review
  3. Article
  4. Article
  5. Review
  6. The apicoplast is important for the viability and persistence ofProceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. NF-κB and Its Regulators During Pregnancy.Frontiers in immunology · 2021
    Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Journal of parasitic diseases : official organ of the Indian Society for Parasitology · 2020
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Anna SaneckaDivision of Parasitology, MRC National Institute of Medical Research, London, UK.
Eva-Maria Frickel

Funding

Medical Research Council MC_UP_1202/12Wellcome Trust
6 · The paper itself

Abstract

The ubiquitous apicomplexan parasite Toxoplasma gondii stimulates its host's immune response to achieve quiescent chronic infection. Central to this goal are host dendritic cells. The parasite exploits dendritic cells to disseminate through the body, produce pro-inflammatory cytokines, present its antigens to the immune system and yet at the same time subvert their signaling pathways in order to evade detection. This carefully struck balance by Toxoplasma makes it the most successful parasite on this planet. Recent progress has highlighted specific parasite and host molecules that mediate some of these processes particularly in dendritic cells and in other cells of the innate immune system. Critically, there are several important factors that need to be taken into consideration when concluding how the dendritic cells and the immune system deal with a Toxoplasma infection, including the route of administration, parasite strain and host genotype.

Indexed as

Host-Pathogen InteractionsAnimalsDendritic CellsHumansImmune EvasionImmunologic FactorsToxoplasmaToxoplasmosisVirulence FactorsImmunologic FactorsVirulence Factorsblood-brain barrierCD8+ T cellsdendritic cellsIFNγIL-12Toll like receptorsToxoplasma gondii

Identifiers

PMID23221473
PMCPMC3545950

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.